These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32798261)

  • 1. The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double-blind randomized clinical trial.
    Pour FK; Aryaeian N; Mokhtare M; Mirnasrollahi Parsa RS; Jannani L; Agah S; Fallah S; Moradi N
    Phytother Res; 2020 Dec; 34(12):3367-3378. PubMed ID: 32798261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Farsi F; Mohammadshahi M; Alavinejad P; Rezazadeh A; Zarei M; Engali KA
    J Am Coll Nutr; 2016; 35(4):346-53. PubMed ID: 26156412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
    Hosseinpour-Arjmand S; Amirkhizi F; Ebrahimi-Mameghani M
    J Clin Pharm Ther; 2019 Apr; 44(2):258-267. PubMed ID: 30585337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Mirhafez SR; Farimani AR; Dehhabe M; Bidkhori M; Hariri M; Ghouchani BF; Abdollahi F
    J Gastrointestin Liver Dis; 2019 Jun; 28():183-189. PubMed ID: 31204416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
    Farhangi MA; Alipour B; Jafarvand E; Khoshbaten M
    Arch Med Res; 2014 Oct; 45(7):589-95. PubMed ID: 25450583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trial.
    Sangsefidi ZS; Hosseinzadeh M; Ranjbar AM; Akhondi-Meybodi M; Fallahzadeh H; Mozaffari-Khosravi H
    Nutr J; 2019 Jul; 18(1):39. PubMed ID: 31324181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial.
    Bahrami M; Cheraghpour M; Jafarirad S; Alavinejad P; Asadi F; Hekmatdoost A; Mohammadi M; Yari Z
    Complement Ther Med; 2020 Aug; 52():102452. PubMed ID: 32951715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of saffron (Crocus sativus L.) in conjunction with concurrent training on body composition, glycaemic status, and inflammatory markers in obese men with type 2 diabetes mellitus: A randomized double-blind clinical trial.
    Hooshmand Moghadam B; Rashidlamir A; Attarzadeh Hosseini SR; Gaeini AA; Kaviani M
    Br J Clin Pharmacol; 2022 Jul; 88(7):3256-3271. PubMed ID: 35001410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral α-lipoic acid supplementation in patients with non-alcoholic fatty liver disease: effects on adipokines and liver histology features.
    Rahmanabadi A; Mahboob S; Amirkhizi F; Hosseinpour-Arjmand S; Ebrahimi-Mameghani M
    Food Funct; 2019 Aug; 10(8):4941-4952. PubMed ID: 31343010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial.
    Kooshki F; Moradi F; Karimi A; Niazkar HR; Khoshbaten M; Maleki V; Pourghassem Gargari B
    Eur J Gastroenterol Hepatol; 2021 Oct; 33(10):1298-1306. PubMed ID: 32804855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An energy-restricted high-protein diet supplemented with β-cryptoxanthin alleviated oxidative stress and inflammation in nonalcoholic fatty liver disease: a randomized controlled trial.
    Haidari F; Hojhabrimanesh A; Helli B; Seyedian SS; Ahmadi-Angali K
    Nutr Res; 2020 Jan; 73():15-26. PubMed ID: 31841744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
    Amanat S; Eftekhari MH; Fararouei M; Bagheri Lankarani K; Massoumi SJ
    Clin Nutr; 2018 Aug; 37(4):1210-1215. PubMed ID: 28647291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
    Pervez MA; Khan DA; Ijaz A; Khan S
    Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial.
    Rashidmayvan M; Vandyousefi S; Barati M; Salamat S; Ghodrat S; Khorasanchi M; Jahan-Mihan A; Nattagh-Eshtivani E; Mohammadshahi M
    Complement Ther Clin Pract; 2022 Aug; 48():101598. PubMed ID: 35567872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of saffron (Crocus sativus L.) supplementation on inflammatory biomarkers: A systematic review and meta-analysis.
    Asbaghi O; Sadeghian M; Sadeghi O; Rigi S; Tan SC; Shokri A; Mousavi SM
    Phytother Res; 2021 Jan; 35(1):20-32. PubMed ID: 32525606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial.
    Darabi Z; Darand M; Yari Z; Hedayati M; Faghihi A; Agah S; Hekmatdoost A
    BMC Res Notes; 2019 Feb; 12(1):89. PubMed ID: 30767788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial.
    Hosseinabadi S; Rafraf M; Asghari S; Asghari-Jafarabadi M; Vojouhi S
    Complement Ther Med; 2020 Mar; 49():102290. PubMed ID: 32147076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
    Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
    Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.
    Sharifi N; Amani R; Hajiani E; Cheraghian B
    Endocrine; 2014 Sep; 47(1):70-80. PubMed ID: 24968737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial.
    Pervez MA; Khan DA; Slehria AUR; Ijaz A
    Complement Ther Med; 2020 Aug; 52():102494. PubMed ID: 32951743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.